ARENA PHARMACEUTICALS INC's ticker is ARNA and the CUSIP is 040047607. A total of 178 filers reported holding ARENA PHARMACEUTICALS INC in Q4 2018. The put-call ratio across all filers is 1.31 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $1,013,000 | +61.0% | 10,904 | +3.1% | 0.03% | +42.9% |
| Q3 2021 | $629,000 | +19.4% | 10,575 | +36.9% | 0.02% | +16.7% |
| Q2 2021 | $527,000 | -2.2% | 7,725 | -0.7% | 0.02% | -10.0% |
| Q1 2021 | $539,000 | -6.6% | 7,778 | +3.5% | 0.02% | -13.0% |
| Q4 2020 | $577,000 | +2.9% | 7,518 | +0.2% | 0.02% | -8.0% |
| Q3 2020 | $561,000 | +18.9% | 7,506 | +0.1% | 0.02% | +8.7% |
| Q2 2020 | $472,000 | +49.4% | 7,500 | -0.3% | 0.02% | +27.8% |
| Q1 2020 | $316,000 | -7.3% | 7,523 | +0.3% | 0.02% | +20.0% |
| Q4 2019 | $341,000 | -0.6% | 7,500 | 0.0% | 0.02% | -6.2% |
| Q3 2019 | $343,000 | -22.0% | 7,500 | 0.0% | 0.02% | -23.8% |
| Q2 2019 | $440,000 | +31.0% | 7,500 | 0.0% | 0.02% | +23.5% |
| Q1 2019 | $336,000 | +15.1% | 7,500 | 0.0% | 0.02% | 0.0% |
| Q4 2018 | $292,000 | -15.4% | 7,500 | 0.0% | 0.02% | -5.6% |
| Q3 2018 | $345,000 | – | 7,500 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 996,898 | $74,558,000 | 6.71% |
| Copernicus Capital Management, LLC | 85,537 | $6,397,000 | 6.09% |
| Prosight Management, LP | 163,057 | $12,195,000 | 5.80% |
| Asymmetry Capital Management, L.P. | 93,308 | $6,979,000 | 4.49% |
| Integral Health Asset Management, LLC | 150,000 | $11,219,000 | 3.43% |
| Avoro Capital Advisors LLC | 3,100,000 | $231,849,000 | 3.29% |
| SECTORAL ASSET MANAGEMENT INC | 409,905 | $30,657,000 | 2.64% |
| BRIDGER MANAGEMENT, LLC | 362,482 | $27,110,000 | 2.17% |
| Blue Rock Advisors, LLC | 31,780 | $2,377,000 | 2.05% |
| First Light Asset Management, LLC | 265,339 | $19,845,000 | 2.03% |